高亲和度的他莫西芬类似物在与卡尔莫杜林结合时保留了广泛的位置障碍
Lilia Milanesi1,2, Clare R Trevitt1, Brian Whitehead1
1Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield S10 2TN, UK.
Magnetic resonance (Gottingen, Germany)
|October 31, 2023
概括
乳腺癌药物伊多西芬与高亲和力结合卡尔莫杜林 (CaM). 这种结合涉及idoxifene在CaM位点之间快速移动,保持CaM.
科学领域:
- 生物化学 生化学
- 结构生物学 结构生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 卡尔莫杜林 (CaM) 是一种关键的结合蛋白,参与细胞信号传递.
- 伊多西芬是一种他莫西芬衍生物,是一种强大的抑制剂,用于研究乳腺癌治疗.
- 了解药物与蛋白质相互作用对于治疗开发至关重要.
研究的目的:
- 阐明载卡尔莫杜林 (CaM) 和伊多西芬之间形成的复合物的结构和动态方面.
- 调查伊多西芬与CaM的结合机制和亲和力.
主要方法:
- 核磁共振 (NMR) 光谱法用于确定结构约束.
- 光测量以评估结合动力学和亲和力.
- 对分子间核重置效应 (NOE) 约束的分析.
主要成果:
- 观察到伊多西芬与CaM (纳米级范围) 的高亲缘关系结合.
- 伊多西芬分子位于CaM的疏水斑点附近,但不会填补口袋.
- 为了满足NOE限制,需要多个idoxifene方向和快速的位置切换.
- 在CaM中,N端和C端域非常接近的形状被采用.
结论:
- 在CaM-伊多西芬复合体表现出高亲缘关系的结合,而不会失去显著的位置动态.
- 伊多西芬的结合方式与较低亲和度的抗体不同,突出显示了独特的相互作用.
- 这项研究提供了关于强效抑制剂如何通过动态相互作用实现高亲和力的见解.
相关概念视频
Calmodulin-dependent Signaling
5.2K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.2K
Transducer Mechanism: Nuclear Receptors
1.4K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.4K
The Two-State Receptor Model
2.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.0K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K


